These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 34930435)

  • 1. Confirmed complete response to nivolumab for advanced gastric cancer with peritoneal dissemination: a case report.
    Takami T; Yasuda K; Uozumi N; Musiake Y; Shintani H; Kataoka N; Yamaguchi T; Makimoto S
    J Med Case Rep; 2021 Dec; 15(1):604. PubMed ID: 34930435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stage IV gastric cancer with microsatellite instability-high achieving long-term survival by gastrectomy after nivolumab as third-line therapy: a case report and literature review.
    Kumagai H; Baba S; Nikai H; Fujisawa R; Shimooki M; Sasaki A
    Surg Case Rep; 2024 Sep; 10(1):221. PubMed ID: 39294523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A Case of Peritoneal Metastasis from an Unresectable Advanced Gastric Cancer with a Good Response to Nivolumab].
    Kumano T; Shibata R; Ota A; Tanaka S; Komatsu S; Imura K; Shimomura K; Ikeda J; Taniguchi F; Shioaki Y
    Gan To Kagaku Ryoho; 2020 Dec; 47(13):2424-2426. PubMed ID: 33468982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conversion surgery for stage IV gastric cancer with a complete pathological response to nivolumab: a case report.
    Matsumoto R; Arigami T; Matsushita D; Okubo K; Tanaka T; Yanagita S; Sasaki K; Noda M; Kita Y; Mori S; Kurahara H; Ohtsuka T
    World J Surg Oncol; 2020 Jul; 18(1):179. PubMed ID: 32693806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Brain Metastasis Arising from Gastric Cancer during Long-Term Treatment Using Nivolumab].
    Namikawa T; Marui A; Yokota K; Kawanishi Y; Munekage M; Uemura S; Maeda H; Kitagawa H; Nagata Y; Kobayashi M; Hanazaki K
    Gan To Kagaku Ryoho; 2022 Dec; 49(13):1544-1546. PubMed ID: 36733129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of liver metastases arising from early gastric cancer achieved clinical complete response by nivolumab.
    Namikawa T; Ishida N; Tsuda S; Fujisawa K; Munekage E; Iwabu J; Munekage M; Uemura S; Tsujii S; Maeda H; Kitagawa H; Kobayashi M; Hanazaki K
    Surg Case Rep; 2018 Jul; 4(1):71. PubMed ID: 29978335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nivolumab in chemotherapy-resistant cervical cancer: report of a vulvitis as a novel immune-related adverse event and molecular analysis of a persistent complete response.
    Baettig F; Vlajnic T; Vetter M; Glatz K; Hench J; Frank S; Bihl M; Lopez R; Dobbie M; Heinzelmann-Schwarz V; Montavon C
    J Immunother Cancer; 2019 Oct; 7(1):281. PubMed ID: 31672171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-Term Survival of an Adolescent and Young Adult Patient with Unresectable Advanced Gastric Cancer in Whom Multidisciplinary Treatment Was Effective].
    Namikawa T; Utsunomiya M; Yokota K; Kawanishi Y; Yamaguchi S; Munekage M; Maeda H; Kitagawa H; Nagata Y; Kobayashi M; Hanazaki K; Seo S
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1985-1987. PubMed ID: 38303273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A Case of Recurrent Gastric Cancer with Long-Term Control via Two Resections and Multidisciplinary Treatment Including Nivolumab].
    Bungo M; Takeno A; Hirao M; Hamakawa T; Yamamoto M; Matsui Y; Tokuyama S; Toshiyama R; Kawai K; Takahashi Y; Sakai K; Doi T; Goto K; Kato T; Takami K
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1715-1717. PubMed ID: 38303183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical complete response after nivolumab administered as a third-line treatment for unresectable advanced gastric cancer with peritoneal dissemination: A case report.
    Komo T; Suzuki T; Tazawa H; Sada H; Morimoto H; Shimada N; Hadano N; Onoe T; Sudo T; Shimizu Y; Tashiro H
    Int J Surg Case Rep; 2021 Jul; 84():106161. PubMed ID: 34237686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors to predict the survival in patients with advanced gastric cancer who receive later-line nivolumab monotherapy-The Asahikawa Gastric Cancer Cohort Study (AGCC).
    Tanaka K; Tanabe H; Sato H; Ishikawa C; Goto M; Yanagida N; Akabane H; Yokohama S; Hasegawa K; Kitano Y; Sugiyama Y; Uehara K; Kobayashi Y; Murakami Y; Kunogi T; Sasaki T; Takahashi K; Ando K; Ueno N; Kashima S; Moriichi K; Sato K; Yuzawa S; Tanino M; Taruiishi M; Sumi Y; Mizukami Y; Fujiya M; Okumura T
    Cancer Med; 2022 Jan; 11(2):406-416. PubMed ID: 34845844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case Report: Complete Remission of a Patient With Metastatic Gastric Cancer Treated With Nivolumab Combined With Chemotherapy After Palliative Surgery.
    Dai P; Rao X; Zhang X; Qiu E; Wu G; Lin Y; Li S; Li Z; Cai Z; Han S
    Front Immunol; 2022; 13():908558. PubMed ID: 35844567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of nivolumab in combination with chemotherapy after radiotherapy for meningeal carcinomatosis in patients with Epstein-Barr virus-associated gastric cancer:a case report].
    Kakinoki K; Asai J; Kida A; Ogawa N; Niwa H; Futatsuya C; Urabe T
    Nihon Shokakibyo Gakkai Zasshi; 2024; 121(9):745-753. PubMed ID: 39261055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Prognostic Factors for Unresectable or Recurrent Gastric Cancer Treated with Nivolumab.
    Ishido K; Tanabe S; Katada C; Ishibashi Y; Kitahara G; Onoue M; Kubota Y; Furue Y; Wada T; Watanabe A; Kusano C
    J Gastrointest Cancer; 2023 Jun; 54(2):485-491. PubMed ID: 35437632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A Case of Initially Unresectable Advanced Gastric Cancer Radically Resected by Conversion Surgery after Nivolumab Immunotherapy].
    Koizumi N; Kashiwagi S; Ogino S; Kamada Y; Fujiki H; Sakakura C
    Gan To Kagaku Ryoho; 2020 Nov; 47(11):1624-1626. PubMed ID: 33268741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathological complete response with nivolumab for recurrence of liver metastasis after gastrectomy of gastric cancer.
    Jun C; Yamauchi S; Yube Y; Egawa H; Yoshimoto Y; Kubota A; Tsuda K; Kaji S; Orita H; Oka S; Mine S; Fukunaga T
    Surg Case Rep; 2023 May; 9(1):86. PubMed ID: 37204618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful Conversion Surgery for Stage IV Gastric Cancer after Nivolumab Monotherapy as Third-Line Chemotherapy.
    Watanabe H; Fujikawa H; Komori K; Kano K; Takahashi K; Yamada T; Inokuchi Y; Machida N; Yokose T; Rino Y; Masuda M; Ogata T; Oshima T
    Case Rep Gastroenterol; 2021; 15(2):562-567. PubMed ID: 34616257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of gastric cancer with delayed onset of tumor reduction effect by nivolumab therapy.
    Satoyoshi R; Muto O; Masuda A; Kotanagi K; Kichiraku T; Kudoh K; Sawada T; Miyazawa H; Kotanagi H
    Clin J Gastroenterol; 2019 Feb; 12(1):15-19. PubMed ID: 30206777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experience with Nivolumab in the Treatment of Metastatic Gastric Cancer].
    Takao C; Matsuhashi N; Murase Y; Yasufuku I; Tanahashi T; Yamaguchi K; Matsui S; Imai H; Tanaka Y; Takahashi T; Yoshida K
    Gan To Kagaku Ryoho; 2018 Oct; 45(10):1546-1548. PubMed ID: 30382073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent gastric cancer sustaining a partial response after the nivolumab discontinuation because of immune-related adverse events: a case report.
    Arigami T; Matsushita D; Okubo K; Tanaka T; Sasaki K; Noda M; Kita Y; Mori S; Tsuruda Y; Kurahara H; Ohtsuka T
    Surg Case Rep; 2020 Oct; 6(1):271. PubMed ID: 33074364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.